<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-VQBSP26X</identifier><date>2020</date><creator>Rajčević, Uroš</creator><relation>documents/doc/V/URN_NBN_SI_doc-VQBSP26X_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VQBSP26X_001.txt</relation><relation>documents/doc/V/URN_NBN_SI_DOC-VQBSP26X_002.pdf</relation><relation>documents/doc/V/URN_NBN_SI_DOC-VQBSP26X_002.txt</relation><format format_type="issue">7/8</format><format format_type="volume">89</format><format format_type="type">article</format><format format_type="extent">str. 398-407</format><identifier identifier_type="DOI">10.6016/ZdravVestn.3006</identifier><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">27862531</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VQBSP26X</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">adoptivna celična terapija</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkologija</subject><title>Adoptivna celična terapija in limfociti T z izraženimi himernimi antigenskimi receptorji</title><title>Adoptive cell therapy and chimeric antigen receptor - T cells</title></Record>